Robotic Water Jet Offers New Hope for Prostate Health

A groundbreaking treatment utilizing a robotic water jet, guided by artificial intelligence, is significantly improving the lives of men suffering from enlarged prostates. This advanced procedure, known as Aquablation, is offered at Cheltenham General Hospital, which has become a regional center of excellence. The treatment employs a high-pressure water jet to meticulously remove obstructing prostate tissue.

Surgeons emphasize that Aquablation preserves vital functions like sexual health and continence, while also facilitating quicker patient recovery compared to traditional surgical methods. Patients like Andy Ocock, who previously relied on a catheter for nearly a year, describe the treatment as life-changing, enabling them to resume normal activities.

Consultant urologist Jeremy Nettleton highlighted the procedure's precision, using ultrasound imaging and AI to guide the water jet with accuracy down to the millimeter. This technology allows for the treatment of benign prostatic hyperplasia (BPH), a common condition affecting millions of men over 50. The success at Cheltenham has led to hundreds of operations and attracted patients nationwide.

For many, the reduced risk of complications is a major draw. Studies indicate a very low incidence of new erectile dysfunction and preservation of ejaculation in approximately 90% of cases. Urinary continence rates are also exceptionally high, with less than half a percent experiencing stress incontinence. This minimally invasive approach is reshaping prostate care and offering renewed quality of life.